News

St. Jude Medical finds FFR clinically beneficial, economically effective

St. Jude Medical found that a two-year analysis of Fractional Flow Reserve-guided intervention strategy can improve health outcomes for patients with multivessel coronary artery disease at lower costs when compared to using angiography alone. FFR is a guide wire-based procedure that can accurately measure blood pressure and flow through a specific part of the coronary […]

St. Jude Medical found that a two-year analysis of Fractional Flow Reserve-guided intervention strategy can improve health outcomes for patients with multivessel coronary artery disease at lower costs when compared to using angiography alone.

FFR is a guide wire-based procedure that can accurately measure blood pressure and flow through a specific part of the coronary artery. Full results for the United Kingdom, France and Italy, and preliminary results in Switzerland and Belgium were announced at EuroPCR in Paris, France, an annual event that highlights the latest techniques, updates and breakthrough science in the cardiovascular field.

The Little Canada, Minnesota-based company found that in the U.K., FFR could prevent on average more than 30 deaths, more than 70 heart attacks and more than 120 major adverse cardiac events over two years. The intervention could also save the British healthcare system more than 300,000 pounds ($487,755) in 2011 and more than 800,000 pounds ($1.3 million) in 2012.

In France, FFR use was shown to prevent on average nearly 300 avoidable deaths, nearly 700 heart attacks and about 1,200 major adverse cardiac events. France could also save 5 million euros ($7.1 million)  in 2011 and more than 11 million euros ($15.7 million) in 2012.